Neuroprotective profile of dextromethorphan in an experimental model of penetrating ballistic-like brain injury

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 1, 2009, Pages 56-62

  Shear, Deborah A ^a   Williams, Anthony J ^a   Sharrow, Keith ^a   Lu, Xi Chun M ^a   Tortella, Frank C ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Cognitive; Dextromethorphan; DM; Motor; NOR; Novel object recognition; PBBI; Penetrating ballistic like brain injury; TBI; Traumatic brain injury

Indexed keywords

DEXTROMETHORPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY EQUILIBRIUM; BRAIN CORTEX; COGNITION; CONTINUOUS INFUSION; CONTROLLED STUDY; CONVALESCENCE; DISEASE MODEL; DRUG DOSE COMPARISON; DRUG EFFICACY; FOLLOW UP; HISTOPATHOLOGY; MALE; MOTOR PERFORMANCE; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; PENETRATING TRAUMA; PRIORITY JOURNAL; RAT; SILVER STAINING; TASK PERFORMANCE; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN INJURIES; COGNITION; DEXTROMETHORPHAN; DIFFUSE AXONAL INJURY; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTAL LOBE; HEAD INJURIES, PENETRATING; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MOTOR ACTIVITY; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOGNITION (PSYCHOLOGY); TIME FACTORS;

RATTUS;

EID: 70349220780     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.07.006     Document Type: Article

References (33)

1. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., and Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17 (1986) 472-476
2. Bell R.S., Vo A.H., Neal C.J., Tigno J., Roberts R., Mossop C., et al. Military traumatic brain and spinal column injury: a 5-year study of the impact blast and other military grade weaponry on the central nervous system. Trauma 66 (2009) S104-111
3. Carpenter C.L., Marks S.S., Watson D.L., and Greenberg D.A. Dextromethorphan and dextrorphan as calcium channel antagonists. Brain Res 439 (1988) 372-375
4. Choi D.W. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity. Brain Res 403 (1987) 333-336
5. D'Esposito M., and Postle B.R. The dependence of span and delayed-response performance on prefrontal cortex. Neuropsychologia 37 (1999) 1303-1315
6. D'Esposito M., Postle B.R., and Rypma B. Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies. Exp Brain Res 133 (2000) 3-11
7. Daffner K.R., Mesulam M.M., Holcomb P.J., Calvo V., Acar D., Chabrerie A., et al. Disruption of attention to novel events after frontal lobe injury in humans. J Neurol Neurosurg Psychiatry 68 (2000) 18-24
8. Daffner K.R., Mesulam M.M., Scinto L.F., Acar D., Calvo V., Faust R., et al. The central role of the prefrontal cortex in directing attention to novel events. Brain 123 Pt 5 (2000) 927-939
9. DeCoster M.A., Klette K.L., Knight E.S., and Tortella F.C. Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res 671 (1995) 45-53
10. Godefroy O., and Rousseaux M. Divided and focused attention in patients with lesion of the prefrontal cortex. Brain Cogn 30 (1996) 155-174
11. Godefroy O., and Rousseaux M. Novel decision making in patients with prefrontal or posterior brain damage. Neurology 49 (1997) 695-701
12. Goldberg M.P., Pham P.C., and Choi D.W. Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture. Neurosci Lett 80 (1987) 11-15
13. Katnik C., Guerrero W.R., Pennypacker K.R., Herrera Y., and Cuevas J. Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia. J Pharmacol Exp Ther 319 (2006) 1355-1365
14. Klette K.L., DeCoster M.A., Moreton J.E., and Tortella F.C. Role of calcium in sigma-mediated neuroprotection in rat primary cortical neurons. Brain Res 704 (1995) 31-41
15. Klette K.L., Lin Y., Clapp L.E., DeCoster M.A., Moreton J.E., and Tortella F.C. Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons. Brain Res 756 (1997) 231-240
16. Lu X.C., Chen R.W., Yao C., Wei H., Yang X., Liao Z., et al. NNZ-2566, a glypromate analog, improves functional recovery and attenuates apoptosis and inflammation in a rat model of penetrating ballistic-type brain injury. J Neurotrauma (2009)
17. Matsumoto R.R., Hemstreet M.K., Lai N.L., Thurkauf A., De Costa B.R., Rice K.C., et al. Drug specificity of pharmacological dystonia. Pharmacol Biochem Behav 36 (1990) 151-155
18. Maurice T., Urani A., Phan V.L., and Romieu P. The interaction between neuroactive steroids and the sigma1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res Brain Res Rev 37 (2001) 116-132
19. Schadel M., Wu D., Otton S.V., Kalow W., and Sellers E.M. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition. J Clin Psychopharmacol 15 (1995) 263-269
20. Senda T., Matsuno K., Okamoto K., Kobayashi T., Nakata K., and Mita S. Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur J Pharmacol 315 (1996) 1-10
21. Steinberg G.K., Bell T.E., and Yenari M.A. Dose escalation safety and tolerance study of the N-methyl-d-aspartate antagonist dextromethorphan in neurosurgery patients. J Neurosurg 84 (1996) 860-866
22. Tortella F.C., Pellicano M., and Bowery N.G. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol Sci 10 (1989) 501-507
23. Tortella F.C., Britton P., Williams A., Lu X.C., and Newman A.H. Neuroprotection (focal ischemia) and neurotoxicity (electroencephalographic) studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-d-aspartate antagonist. J Pharmacol Exp Ther 291 (1999) 399-408
24. Walker F.O., and Hunt V.P. An open label trial of dextromethorphan in Huntington's disease. Clin Neuropharmacol 12 (1989) 322-330
25. Walker J.M., Bowen W.D., Walker F.O., Matsumoto R.R., De Costa B., and Rice K.C. Sigma receptors: biology and function. Pharmacol Rev 42 (1990) 355-402
26. Werling L.L., Lauterbach E.C., and Calef U. Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action. Neurologist 13 (2007) 272-293
27. Williams A.J., Dave J.R., Phillips J.B., Lin Y., McCabe R.T., and Tortella F.C. Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-d-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies. J Pharmacol Exp Ther 294 (2000) 378-386
28. Williams A.J., Hartings J.A., Lu X.C., Rolli M.L., Dave J.R., and Tortella F.C. Characterization of a new rat model of penetrating ballistic brain injury. J Neurotrauma 22 (2005) 313-331
29. Williams A.J., Hartings J.A., Lu X.C., Rolli M.L., and Tortella F.C. Penetrating ballistic-like brain injury in the rat: differential time courses of hemorrhage, cell death, inflammation, and remote degeneration. J Neurotrauma 23 (2006) 1828-1846
30. Williams A.J., Ling G.S., and Tortella F.C. Severity level and injury track determine outcome following a penetrating ballistic-like brain injury in the rat. Neurosci Lett 408 (2006) 183-188
31. Williams A.J., Wei H.H., Dave J.R., and Tortella F.C. Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat. J Neuroinflammation 4 (2007) 17
32. Zhang H., and Cuevas J. Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 87 (2002) 2867-2879
33. Zhou G.Z., and Musacchio J.M. Computer-assisted modeling of multiple dextromethorphan and sigma binding sites in guinea pig brain. Eur J Pharmacol 206 (1991) 261-269